Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections the diamond randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 317, Issue 4, 2017, Pages 371-378

  Beck, Roy W ^a   Riddlesworth, Tonya ^a   Ruedy, Katrina ^a   Ahmann, Andrew ^b   Bergenstal, Richard ^c   Haller, Stacie ^d   Kollman, Craig ^a   Kruger, Davida ^e   McGill, Janet B ^f   Polonsky, William ^g   Toschi, Elena ^h   Wolpert, Howard ^h   Price, David ⁱ  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c INTERNATIONAL DIABETES CENTER   (United States)

^d Diabetes and Glandular Disease Clinic   (United States)

^e HENRY FORD HOSPITAL   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g Behavioral Diabetes Institute   (United States)

^h JOSLIN DIABETES CENTER   (United States)

ⁱ DexCom Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ANALYTICAL PARAMETERS; BLOOD GLUCOSE METER; CLINICAL EFFECTIVENESS; CONFERENCE PAPER; CONTINUOUS GLUCOSE MONITORING; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLYCEMIC CONTROL; GLYCEMIC VARIABILITY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE DAILY INSULIN INJECTION; OUTCOME ASSESSMENT; PATIENT MONITORING; PATIENT SATISFACTION; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; WEIGHT CHANGE; AGED; ANALYSIS; BLOOD; BLOOD GLUCOSE MONITORING; CHEMICALLY INDUCED; CLINICAL TRIAL; DEVICES; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; TIME FACTORS;

EID: 85011898350     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.19975     Document Type: Conference Paper

References (22)

1. Miller KM, Foster NC, Beck RW, et al; T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015; 38(6): 971-978.
2. Battelino T, Conget I, Olsen B, et al; SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012; 55(12): 3155-3162.
3. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011; 34(4): 795-800.
4. Bergenstal RM, TamborlaneWV, Ahmann A, et al; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010; 363(4): 311-320.
5. TamborlaneWV, Beck RW, Bode BW, et al; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359(14): 1464-1476.
6. Beck RW, Hirsch IB, Laffel L, et al; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009; 32(8): 1378-1383.
7. Grunberger G, Abelseth JM, Bailey TS, et al. Consensus statement by the American Association of Clinical Endocrinologists/American College of Endocrinology Insulin Pump Management Task Force. Endocr Pract. 2014; 20(5): 463-489.
8. Pickup J. Insulin pumps. Int J Clin Pract Suppl. 2011; 65(170): 16-19.
9. Foster NC, Miller KM, TamborlaneWV, Bergenstal RM, Beck RW; T1D Exchange Clinic Network. Continuous glucose monitoring in patients with type 1 diabetes using insulin injections. Diabetes Care. 2016; 39(6): e81-e82.
10. ClarkeWL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, PolonskyW. Reduced awareness of hypoglycemia in adults with IDDM: a prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995; 18(4): 517-522.
11. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther. 2010; 12(9): 679-684.
12. Little RJA, Rubin DB. Statistical Analysis With Missing Data. New York, NY: John Wiley & Sons; 1987.
13. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984; 79(387): 516-524.
14. Kovatchev BP, Cox DJ, Farhy LS, Straume M, Gonder-Frederick L, ClarkeWL. Episodes of severe hypoglycemia in type 1 diabetes are preceded and followed within 48 hours by measurable disturbances in blood glucose. J Clin Endocrinol Metab. 2000; 85(11): 4287-4292.
15. Fiallo-Scharer R, Cheng J, Beck RW, et al; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. Diabetes Care. 2011; 34(3): 586-590.
16. Brod M, Wolden M, Christensen T, Bushnell DM. A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes Obes Metab. 2013; 15(6): 546-557.
17. Davis RE, MorrisseyM, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin. 2005; 21(9): 1477-1483.
18. Fulcher G, Singer J, Castañeda R, et al. The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys. J Med Econ. 2014; 17(10): 751-761.
19. Battelino T, Liabat S, Veeze HJ, Castañeda J, Arrieta A, Cohen O. Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus. Diabet Med. 2015; 32(12): 1568-1574.
20. Bailey TS, Chang A, Christiansen M. Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol. 2015; 9(2): 209-214.
21. Christiansen M, Bailey T, Watkins E, et al. A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system. Diabetes Technol Ther. 2013; 15(10): 881-888.
22. Zisser HC, Bailey TS, Schwartz S, Ratner RE, Wise J. Accuracy of the SEVEN continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements. J Diabetes Sci Technol. 2009; 3(5): 1146-1154.